Article
Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells.
Biochemical pharmacology - 15 Oct 1998
Landau M, Weizman A, Zoref-Shani E, Beery E, Wasseman L, Landau O, Gavish M, Brenner S, Nordenberg J
Abstract excerpt
In this study, we evaluated the effect of several ligands active at the central-type and peripheral-type benzodiazepine receptor (BzR) (clonazepam, diazepam, PK11195 and Ro5-4864) on the growth and differentiation of B16 melanoma cells. All tested BzR ligands were able to suppress proliferation of the cells at the micromolar range and in a concentration-dependent manner. However, agents selectively active at the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
